Need professional-grade analysis? Visit stockanalysis.com
$10.63B
495.39
5,297
0.82%
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY3.54, down 2.75% from the previous close.
Over the past year, 300026 has traded between a low of CNY3.29 and a high of CNY4.33. The stock has gained 6.5% over this period. It is currently 18.2% below its 52-week high.
Tianjin Chase Sun Pharmaceutical Co Ltd has a market capitalization of $10.63B, with a price-to-earnings ratio of 495.39 and a dividend yield of 0.82%.
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 and is headquartered in Tianjin, China.
Side-by-side comparison against top Healthcare peers.